An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored
Intramuscular
Progressive juvenile idiopathic arthritis
Child: 1 mg/kg wkly. Max: 50 mg wkly. Calculated initial wkly dose may be preceded by a smaller test dose such as 1/10 or 1/5 of the full dose for 2-3 wk. Continue wkly doses until signs of remission occur then increase dosage intervals to 2 wk. W/ full remission, dosage interval may be increased gradually to 4 wk. If no improvement after 20 wk, dose may be raised slightly or another antirheumatic drug may be tried.
Renal impairment: Severe: Contraindicated.
Hepatic impairment: Severe: Contraindicated.
Intramuscular
Active progressive rheumatoid arthritis
Adult: Initially, 10 mg in the 1st wk as test dose, followed by 50 mg wkly until signs of remission occur. Dosage interval is then increased to 2 wk until full remission, then increased gradually to 4-6 wk. May continue for up to 5 yr after complete remission. Discontinue if no major improvement is seen after a total of 1 g (excluding test dose) has been given, or alternatively, in the absence of toxicity, 100 mg may be given wkly for a further 6 wk. Discontinue if there is no sign of remission.
Renal impairment: Severe: Contraindicated.
Hepatic impairment: Severe: Contraindicated.
Tauredon description
sponsored
Tauredon is a gold compound that is used for its immunosuppressive anti-rheumatic effects. Along with an orally-administered gold salt, auranofin, it is one of only two gold compounds currently employed in modern medicine.
Tauredon dosage
Intramuscular
Progressive juvenile idiopathic arthritis
Child: 1 mg/kg wkly. Max: 50 mg wkly. Calculated initial wkly dose may be preceded by a smaller test dose such as 1/10 or 1/5 of the full dose for 2-3 wk. Continue wkly doses until signs of remission occur then increase dosage intervals to 2 wk. W/ full remission, dosage interval may be increased gradually to 4 wk. If no improvement after 20 wk, dose may be raised slightly or another antirheumatic drug may be tried.
Renal impairment: Severe: Contraindicated.
Hepatic impairment: Severe: Contraindicated.
Intramuscular
Active progressive rheumatoid arthritis
Adult: Initially, 10 mg in the 1st wk as test dose, followed by 50 mg wkly until signs of remission occur. Dosage interval is then increased to 2 wk until full remission, then increased gradually to 4-6 wk. May continue for up to 5 yr after complete remission. Discontinue if no major improvement is seen after a total of 1 g (excluding test dose) has been given, or alternatively, in the absence of toxicity, 100 mg may be given wkly for a further 6 wk. Discontinue if there is no sign of remission.
Renal impairment: Severe: Contraindicated.
Hepatic impairment: Severe: Contraindicated.
Tauredon interactions
sponsored
Drug Interaction: May increase risk of aspirin-induced liver damage. Increased risk of severe anaphylactoid reaction when used w/ ACE inhibitors.
Potentially Fatal: Increased risk of blood dyscrasias and other severe adverse effects (e.g. proteinuria) when used concomitantly w/ myelossupressive agents, phenylbutazone, penicillamine and antimalarials.
Stomatitis; corneal gold deposition; corneal ulceration; iritis; conjunctivitis; metallic taste. Children: Safety and efficacy in children younger than 6 yr of age have not been established.
GI
Diarrhea; nausea; cholestatic jaundice; ulcerative enterocolitis; GI bleeding; difficulty swallowing; abdominal pain and cramping.
Genitourinary
Nephrotic syndrome or glomerulitis with proteinuria and hematuria.
Anaphylactoid reactions within minutes of injection, arthralgias for several days after injection, “nitritoid reaction” (eg, vasomotor reaction with flushing, fainting, weakness, dizziness, sweating, nausea, vomiting, malaise and headache).
Tauredon contraindications
sponsored
Exfoliative dermatitis, SLE, necrotising enterocolitis, pulmonary fibrosis. History of haematological disorders, toxicity to heavy metals. Severely debilitated patients. Severe renal or hepatic impairment. Concomitant use w/ antimalarials, immunosuppressive agents, penicillamine or phenylbutazone.
The results of a survey conducted on ndrugs.com for Tauredon are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Tauredon. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
User reports
Consumer reported useful
No survey data has been collected yet
Consumer reported price estimates
No survey data has been collected yet
1 consumer reported time for results
To what extent do I have to use Tauredon before I begin to see changes in my health conditions? As part of the reports released by ndrugs.com website users, it takes 3 month and a few days before you notice an improvement in your health conditions. Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Tauredon. To get the time effectiveness of using Tauredon drug by other patients, please click here.
Users
%
3 month
1
100.0%
4 consumers reported age
Users
%
> 60
2
50.0%
30-45
1
25.0%
46-60
1
25.0%
Consumer reviews
There are no reviews yet. Be the first to write one!
